IPAC - International Pharmaceutical Aerosol Consortium
Home
MDI FAQ
Member Companies
Calendar
Physician and Patient Resources
Info and Data on the MDI Transition
Resources
Physician and  Patients Resources
 

Inhaler Therapy

Guidelines for the treatment of asthma and chronic obstructive pulmonary disease (COPD) recommend the use of inhaled therapy because it allows a lower dose of drug to be delivered directly to the lungs than would be possible with a tablet, and therefore reduces the potential for side effects.

The metered dose inhaler (MDI) is a pocket-sized, hand-held, pressurised multiple-dose inhal-ation system which efficiently delivers a consistent, measured dose of medicine into the lungs.

The MDI has proven safe, effective and reliable for virtually all patients, and is the mainstay of successful asthma therapy worldwide. The MDI accounts for approximately 70 percent of all inhalation therapy in the world’s fifteen largest patient populations.


Essential Components of an MDI

The essential components of an MDI are a storage canister; a medicinal formulation, including both the propellant and the active ingredient; a metering valve to control the discharge of precise doses of formulation; and an actuator. The storage canister is placed valve-down into the actuator. In press-and-breathe MDIs, the patient pushes down on the canister to release a dose. Breath-actuated MDIs release the required dose of medication automatically as the patient breathes in.

Inside the MDI canister is a complex formulation consisting of one or more drug substances; one or more propellants; and perhaps a co-solvent and/or surfactant.


How an MDI Functions

The propellant mixture is made up of one or more liquefied gases which generate a pressure of 50-80 psi inside the canister. Upon release from the MDI, the propellant flash evaporates, changing from a liquid to a gas. The result is a respirable mist of the medicine that was suspended or dissolved in the formulation.
The function of an MDI is the consistent delivery of an accurate amount of medication as an aerosol. This allows deposition in the passageways of the lungs.


Characteristics of MDIs

The availability of a wide range of therapy options, including MDIs, dry powder inhalers and nebulisers, ensures that individual patients receive the best possible treatment tailored to suit their personal circumstances. MDIs, often with a spacer or breath activated device, possess numerous characteristics that, taken together, make them widely acceptable to millions of patients.

  • MDI propellants provide the energy needed for drug delivery independent of any external power source or extra inspiratory effort on the part of the patient.

  • In MDIs, the delivered dose depends significantly on the metering valve and formulation, as opposed to patient inspiration.

  • A patient who needs multiple medications can operate a variety of MDIs using the same technique.

  • MDIs provide good protection from humidity during use.

  • MDIs are widely available for inhalation of all of the most commonly used respiratory medications.

  • MDIs can be adapted to meet the needs of special patient populations, including young children and infants, e.g. by adding spacers.

MDIs offer patients a unique combination of benefits. Thus, they are a vital therapy option for patients with asthma and other respiratory diseases.